Tissue engineering of cartilage using an injectable and adhesive chitosan-based cell-delivery vehicle
Adult articular cartilage shows a limited intrinsic repair response to traumatic injury. To regenerate damaged cartilage, cell-assisted repair is thus viewed as a promising therapy, despite being limited by the lack of a suitable technique to deliver and retain chondrogenic cells at the defect site....
Saved in:
Published in | Osteoarthritis and cartilage Vol. 13; no. 4; pp. 318 - 329 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
01.04.2005
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Adult articular cartilage shows a limited intrinsic repair response to traumatic injury. To regenerate damaged cartilage, cell-assisted repair is thus viewed as a promising therapy, despite being limited by the lack of a suitable technique to deliver and retain chondrogenic cells at the defect site.
We have developed a cytocompatible chitosan solution that is space-filling, gels within minutes, and adheres to cartilage and bone
in situ. This unique combination of properties suggested significant potential for its use as an arthroscopically injectable vehicle for cell-assisted cartilage repair. The primary goal of this study was to assess the ability of this polymer system, when loaded with primary articular chondrocytes, to support cartilage formation
in vitro and
in vivo. The chitosan gel was cultured
in vitro, with and without chondrocytes, as well as injected subcutaneously in nude mice to form subcutaneous dorsal implants.
In vitro and
in vivo constructs were collectively analyzed histologically, for chondrocyte mRNA and protein expression, for biochemical levels of glycosaminoglycan, collagen, and DNA, and for mechanical properties.
Resulting tissue constructs revealed histochemical, biochemical and mechanical properties comparable to those observed
in vitro for primary chondrocytes cultured in 2% agarose. Moreover, the gel was retained after injection into a surgically prepared, rabbit full-thickness chondral defect after 1 day
in vivo, and in rabbit osteochondral defects, up to 1 week.
The
in situ-gelling chitosan solution described here can support
in vitro and
in vivo accumulation of cartilage matrix by primary chondrocytes, while persisting in osteochondral defects at least 1 week
in vivo. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1063-4584 1522-9653 |
DOI: | 10.1016/j.joca.2004.12.001 |